Rachel McMinn

Rachel McMinn

Verkställande Direktör på
Neurogene, Inc.

Förmögenhet: 43 M $ per 2026-07-31

53 år
Finance
Health Technology
Consumer Services

Profil

Rachel L.
McMinn
is the founder of Neurogene OpCo., founded in 2018, serving as Chief Executive Officer since 2019.
Dr. McMinn is the founder of Neurogene, Inc., founded in 2018, serving as Executive Chairman & Chief Executive Officer since 2023.
Dr. McMinn is currently Director at EveryONE Medicines, Inc. since 2021.
Former positions include Director at Cowen & Co. LLC.
from 2007 to 2009, Senior Analyst at Piper Sandler & Co. (Broker), Chief Business & Strategy Officer at Intercept Pharmaceuticals, Inc. from 2014 to 2017, Principal at Banc of America Securities LLC in 2009, Analyst at Piper Sandler & Co., and Analyst at Merrill Lynch, Pierce, Fenner & Smith, Inc. Education includes a doctorate from The Scripps Research Institute and an undergraduate degree from Cornell University.

Kända innehav i offentliga företag

FöretagDatumAntal aktierVärderingVärderingsdatum
8,36 %
2026-04-07 1 302 474 ( 8,36 % ) 43 M $ 2026-07-31

Aktiva positioner av Rachel McMinn

FöretagPositionStart
Verkställande Direktör 2018-01-01
Direktör/Styrelseledamot 2021-01-01

Tidigare kända positioner av Rachel McMinn

FöretagPositionSlut
INTERCEPT PHARMACEUTICALS, INC. Företagsledare/Principal 2017-12-01
Analyst-Equity 2009-04-30
Analyst-Equity 2009-03-31
Analyst-Equity 2006-12-31
Företagsledare/Principal -
Se detaljerna i Rachel McMinns erfarenhet

Rachel McMinns utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

62

Första gradens relationer

10

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag10

Finance

Finance

Health Technology

Consumer Services

Finance

Consumer Services

Finance

Finance

Health Technology

Commercial Services

  1. Börsen
  2. Insiders
  3. Rachel McMinn